Getting excited about benign radiotherapy! - Simul Parikh
ACRO - American College of Radiation Oncology Bobby Koneru, MD Mudit Chowdhary, MD Jona Hattangadi-Gluth, MD

#ASTRO #ASTRO News #Cancer #MusculoskeletalPain #OncoDaily #Oncology #Radiotherapy

oncodaily.com/47106.html

No SUNSET on this ultracentral trial of 60 Gy in 8 fractions
<7% grade 3-5 AEs, ~90% local control
Online at: redjournal.org/article/S0360-…
Meredith Giuliani Benjamin Lok, MD Alex Louie MD, PhD Houda Bahig, MD PhD Andrea Bezjak Scott Bratman Dr. David Palma

Total solar eclipse in Cleveland. Happy to have a short down time in between cases to capture this! Cleveland Clinic

DOSIS - RCT in pts with painful vertebral mets
Hypothesis: improved LC -> durable pain response
First randomized trial with 6 mo pain reduction as prim endpoint
N=63 pts randomized to SBRT vs conv. RT
Significant benefit of SBRT: 69.4% vs. 41.9% (p=0.02)
doi.org/10.1002/cncr.3…

If you aren’t cheating, you aren’t trying!

Are you looking at MRIs?

Feeling some confusion about the diffusion?

Feel impaired when it comes to the FLAIR?

Wish you could cheat a little?

Here’s a little cheat sheet on all the sequences you NEED to know if you are looking at…

🔥Big News

Press Release: Ph III ADRIATIC Trial meets OS & PFS Endpoints for Durva v Placebo in Limited Stage SCLC:

- 730pts with LS-SCLC post cCRT
- pts randomised to Durva +/- Treme post cCRT v pbo

Can't wait to see the full data
OncoAlert #LCSM
astrazeneca.com/media-centre/p…

Focal boost for #prostatecancer
IJROBP - The Red Journal home of all of the amazing things you can do with radiation
redjournal.org/article/S0360-…

Retrospective study NSCLC pts brain-only M+
- 103 pts: SRS of brain mets in all pts, definitive Tx of primary in 51%
- Local TX of primary associated with ⬆️ PFS & OS
- MVA for OS: definitive TX of primary, TX with IO, and AJCC stage
👏 Beaumont Radiation Oncology
thegreenjournal.com/article/S0167-…

Dr. Antoinette Wozniak with an EXCELLENT discussion of the exploding peri-operative space in resectable NSCLC at IASLC Best of #TTLC24 webinar. What will push us toward neoadj vs perioperative? pCR? MRD? impt research questions that need answering.

Shankar Siva (Shankar Siva) of Peter MacCallum Cancer Centre (@petermaccc) in Australia spoke with CURE® via email about radiotherapy as a non-invasive option for patients with #KidneyCancer .

Read for more info: curetoday.com/view/radiother…

After my initial list yesterday, both Todd Scarbrough and Jordan Johnson showed me additional organizations supporting permanent 'Virtual Direct Supervision'.

Simultaneously, it came to my attention that individual practices are being told that various organizations 'support…

We made it! Today we completed accrual for the SABR-COMET-10 trial!

As far as I know, it's the first phase III oligomets trial to complete accrual.

A few thoughts below... 🧵

I finally read CROSSFIRE (IRE vs. MRI-guided SBRT after chemo in locally advanced pancreas cancer) in detail.

There are a few issues. Brief thread.

thelancet.com/journals/langa…

In advance of Friday's “Town Hall” (more accurately: “Webinar Presentation”), I took the liberty of creating a list of professional societies/organizations that have written to CMS in support of “Virtual Direct Supervision” becoming permanent.

This list is not comprehensive, of…

Kevin Lee, an MS4 The Ohio State University College of Medicine + newly matched into Neurology was diagnosed with a rare brain cancer in March of 2024.

Since his diagnosis, he’s had a brain biopsy, multiple LPs, and just finished his first round of chemotherapy.

Delighted to share our latest article featuring a modified #QUADSHOT regimen born from #realworld practice, emphasizing #oralcancer . Huge thanks to Indranil Mallick Santam Chakraborty sanjoy for the invaluable guidance and support! Read more: doi.org/10.1002/hed.27…
#palliative

🫁🧠Brain metastases of NSCLC

Osimertinib plus local treatment Vs. Osimertinib alone❓
ESMO - Eur. Oncology

✅OS and CNS-PFS were significantly longer with upfront local therapy plus osimertinib than osimertinib alone
✅HRs 0.37 0.16–0.87) and 0.36 (0.15–0.87), respectively…

It's Official.

The agenda for the May 2024 AMA CPT® Editorial Panel Meeting includes a proposal to establish CPT codes for prior authorization + appeal of wrongful denials.

ama-assn.org/system/files/c…

#PriorAuthCPT #WrongfulDenialAppealCPT

1/15

Excellent plenary session talk by Mark Fairweather adding more proof that neoadjuvant RT has a role for primary RP WDLPS ⁦Brigham and Women’s Department of Surgery⁩ ⁦BWH Surgical Oncology⁩ ⁦TARPSWG⁩ #SSO2024

A new 🌟 TARPSWG achievement: solid data on the largest series of WDLPS #retroperitoneal #sarcoma : after Neoadjuvant RT significantly reduced local recurrence rate Vs surgery alone. #STRASS and #STREXIT data are now corroborated. Great job Mark Fairweather! #SSO2024 #plenary